Statistics for Pliant Therapeutics (id:7634 PLRX)

Valuation metrics

Market cap

756.41M

Enterprise value

412.11M

Trailing P/E (ttm)

-4.72

Forward P/E

-3.09

PEG ratio

-3.09

Price/Sales (ttm)

478.74

Price/Book (mrq)

2.19

Enterprise Value/Revenue

260.83

Enterprise Value/EBITDA

-1.87

Overview

Shares outstanding

60.85M

Float

46.87M

Shares short

7.22M

% Held by insiders

0.03%

% Held by institutions

1.12%

Average volume (10 days)

470.85K

Average volume (90 days)

Price summary

52-Week low

10.22

52-Week high

19.62

52-Week change

-9.24%

Beta

1.09

50-Day moving average

13.08

200-Day moving average

13.45

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-10,130.95%

Operational effectiveness

Return on assets

-28.15%

Return on equity

-47.52%

Income statement

Revenue (ttm)

0.03

Revenue per share (ttm)

0.03

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-219,951,008.00

Net income to common (ttm)

-201,680,992.00

Diluted EPS (ttm)

-3.35

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

404.51M

Total cash per share (mrq)

6.65

Total debt (mrq)

60.21M

Total Debt/Equity (mrq)

17.41

Current ratio (mrq)

1.03K%

Book value per share (mrq)

5.68

Cash flow

Cash flow statement

-132,943,000.00

Levered free cash flow (LFCF)

-84,077,624.00